Prevention of TACO what Haemovigilance data tell us

Similar documents
How we View & Approach TACO

TACO CASE STUDIES RTC JUNE Kerry Dowling Blood Transfusion Laboratory Manager Jonathan Ricks Blood Transfusion Nurse Practitioner

Have you ever managed patients who have experienced an adverse reaction to transfusion?

Boot Camp Transfusion Reactions

TACO: a call to action

Haemovigilance Annual report 2012

Blood is serious business

Transfusion Reactions:

Transfusion Associated Acute Lung Injury (TRALI)

Transfusion Associated Acute Lung Injury (TRALI) Chris Beritela, MS, MT(ASCP)SBB Area Technical Consultant Immucor, Inc.

REPORT OF TRANSFUSION ADVERSE REACTION TO BLOOD CENTERS

Haemovigilance: Acute transfusion reactions. Paula Bolton-Maggs Medical Director Serious Hazards of Transfusion

Definitions of Current SHOT Categories & What to Report

Pulmonary complications in the Elderly. Paula Bolton-Maggs Medical Director

TACO Est ce que cette complication transfusionnelle peut être prédite et prévenue?

Approach to a patient with suspected blood transfusion reaction. Raju Vaddepally, MD

Dr Rock LEUNG Transfusion Safety Officer Queen Mary Hospital, Hong Kong West Cluster

Transfusion Reactions

EDUCATIONAL COMMENTARY TRANSFUSION-RELATED ACUTE LUNG INJURY

Blood/Blood Component Utilization and Administration Annual Compliance Education

Management of TRALI. Handouts. Continuing Education 5/20/2015.

Transfusion reactions. Jim Taylor Haematology SpR Sheffield

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests

Mary Berg, M.D. Medical Director, Transfusion Services Associate Professor of Pathology University of Colorado Hospital

Haemovigilance Annual report 2013 Summer 2014

Current Concepts Transfusion Morbidity & Mortality St. Charles Health System Grand Rounds, Bend, Oregon. Agenda. Serious Consequences of Transfusion

National Haemovigilance Programme

Transfusion Related Respiratory Complications:

Transfusion Medicine Potpourri. BUMC - Phoenix Internal Medicine Residents September 29, 2015

Revised November 2012

Transfusion-Related Acute Lung Injury (TRALI) and Strategies for Prevention. Khalid Abdulla Sharif, MD, MRCP (UK)*

Blood Transfusion. Dr William Dooley

Administration of blood components. Tina Parker - Transfusion Practitioner

Acute Transfusion Reactions (Allergic, Hypotensive and Severe Febrile) (ATR) n=296 11

Transfusion Reactions. Directed by M-azad March 2012

Blood Transfusion Reactions

Update on ISBT Interna/onal Survey on Transfusion- transmi9ed Bacterial Infec/ons

Frequency and Pattern of Noninfectious Adverse Transfusion Reactions at a Tertiary Care Hospital in Korea

Blood Transfusion. Dr Will Dooley

Blood transfusions in sepsis, the elderly and patients with TBI

Haemovigilance Report 2013

27/01/2019. Anaemia, Transfusion and TACO Lise Estcourt. Anaemia. What is anaemia?

MB Guideline 7. Transfusion Reaction- Identification, Management and Reporting

Transfusion-related Acute Lung Injury: Report of Two Cases

Thinking Twice About Transfusions: When TACOS and TRALIs Turn Treatment Into Tragedy. Megan Boysen Osborn, MD, MHPE

TRANSFUSION SAFETY 101 ARE YOU SMARTER THAN A BLOOD BANKER?

Transfusion Challenges. - Transfusion Reactions - Do they need platelets? Dr. Eoghan Molloy Haem SpR 2016

Transfusion-related Acute Lung Injury (TRALI) University of California, San Francisco January 8, 2011

METHYLENE BLUE-TREATED FRESH FROZEN PLASMA AND RELATED ADVERSE REACTIONS IN FRANCE: THE LONGER THE EXPERIENCE THE MORE ROBUST THE RESULTS

Transfusion reactions illustrated

MabThera. SC. The wait is over. MabThera delivered in just 5 minutes. SC= subcutaneous injection

COMPLICATIONS OF BLOOD TRANSFUSIONS. :Prepared by Dr. Nawal Mogales & Dr. Mohammed Aqlan

R-Gemcitabine (1000mg/m 2 ) Oxaliplatin Therapy i - 14 day

2/2/2011. Blood Components and Transfusions. Why Blood Transfusion?

CrackCast Episode 7 Blood and Blood Components

Chapter 13 ADVERSE TRANSFUSION EVENTS

EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL

Febrile Non-haemolytic Transfusion Reactions. Sue Knowles Epsom and St Helier University Hospitals NHS Trust. Copyright BBTS 2008

Blood Management: Improve Transfusion, Decrease Costs!

ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv

Oxygen Use in Palliative Care Guideline and Flowchart

ANAPHYLAXIS Following Vaccination. A Severe Adverse Event. Developed for the Grampians Infection Control Group (GRICG) Version 2.

TRANSFUSION REACTION AMONG THE BLOOD RECIPIENT - A STUDY OF 120 CASES

Lecture Notes. Chapter 2: Introduction to Respiratory Failure

Haemovigilance by JRCS

RiTUXimab 375 mg/m 2 Therapy-7 day

Transfusion Reactions. Objectives. 1) Identify a transfusion reaction 25/02/16. Dr Matthew Horan. 1) Identify a transfusion reaction

Azathioprine toxicity criteria and severity descriptors for the listing of biological agents for rheumatoid arthritis on the PBS

25/10/2017. Clinical Relevance of the HLA System in Blood Transfusion. Outline of talk. Major Histocompatibility Complex

-Cardiogenic: shock state resulting from impairment or failure of myocardium

London, 24 January 2000 EMEA/1952/00

WRHA Blood Conservation Service WRHA Transfusion Practice Committee. TEAM TRANSFUSION Differential Diagnosis of Adverse Events

A Transfusion Reaction What Do I Do Now? Judith A. Sullivan, MS, MT(ASCP)SBB, CQA(ASQ) ASCLS Region III Triennial Meeting Birmingham AL

Transfusion 2004: Current Practice Standards. Kay Elliott, MT (ASCP) SBB SWMC Transfusion Service

Summary of the Risk Management Plan (RMP) V. 1.6, July 2017 for BAVENCIO. Avelumab 200 mg/10 ml. Concentrate for Solution for Infusion

2:39 2: Dizziness and nausea Cerebral. 2:57 1: Vomiting Gastro-intestinal

Patient Blood Management. Marisa B. Marques, MD UAB Department of Pathology November 17, 2016

June For 2010, Swissmedic compiled annual pharmacovigilance statistics in the following sectors:

Paula Bolton-Maggs Medical Director SHOT

Olive J Sturtevant, MHP, MT(ASCP)SBB/SLS, CQA Director, Cellular Therapy Quality Assurance Dana Farber Cancer Institute

Figure 1: ATEs related to transfused products per year (N=1,040). 8

BC Cancer Protocol Summary for Treatment of Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia with Fludarabine and rituximab

A transfusion reaction is any adverse effect of transfusion therapy which occurs during or after administration of a blood component

ANAPHYLAXIS. Following Vaccination of Adults. A Severe Adverse Event

National Haemovigilance Programme. Annual Report 2012

Product Information BROWN SNAKE ANTIVENOM AUST R 74897

Alister Jones Patient Blood Management Practitioner NHS Blood and Transplant

Bronchospasm & SOB. Kim Kilmurray Senior Clinical Teaching Fellow

Chest diseases Hospital Laboratory Hematology Practice guidelines

HAEMOVIGILANCE REPORT 2016

DERBY-BURTON CANCER NETWORK CONTROLLED DOC NO:

TRANSFUSION OF BLOOD COMPONENTS ADMINISTRATION. All blood components are administered according to BOP DHB Policy and NZBS Guidelines.

French National Experience. EFS Medical Director

TRANSFUSION TRANSMITTED INJURIES SURVEILLANCE SYSTEM (TTISS): SUMMARY RESULTS. 1 P age

Management of an immediate adverse event following immunisation

ISBN: Haemovigilance Report 2011

Acute respiratory failure. Arterial blood gas assessment. finn rasmussen 2011

Be courteous to your classmates! Please set your cell phones and/or pagers to silent or turn them off.

Keeping track of your numbers

Transcription:

Prevention of TACO what Haemovigilance data tell us Swisstransfusion, Genève 6. Septembre 03 Markus Jutzi, Morven Rüesch Clinical Reviewer Haemovigilance, Swissmedic Swissmedic Schweizerisches Heilmittelinstitut Hallerstrasse 7 CH-3000 Bern www.swissmedic.ch

Current Haemovigilance data Transfusion reactions 0 by classification and frequency,% 3.9%,3% 0,5%,0% 0,% 0,% 0,5% 0,% 8,% 7,7% 43,5% FNHTR Allo-immunisation Allergic TR TACO Hypotensive TR Other Haemolytic TR Infection TAD Hyperkalaemia TRALI PTP 59 % High imputability TR s

Imputability and severity High imputability: ~ 60 % of all reported transfusion reactions (TR s) ~ 60 % of reported TACO Severity grade 3 or 4 (life threatening or fatal).7 % of all reported TR s 5 % of reported TACO 3

Number of cases Life threatening and fatal cases Grade 3&4 TRs 008-0 Fatal TR's 00-0 35 30 5 0 5 0 4 6 7 0 8 8 4 6 Other Hyperkalaemia Delayed HTR TAD Hypotensive TR Bacterial infection TRALI Acute HTR 3 TRALI Bacterial infection Acute haemolytic TR TACO 5 0 008 009 00 0 0 8 TACO Allergic TR 0 Year 4

Comparison of cumulative incidence (reported TACO cases per blood components transfused) Blood component All components Red cell concentrates Québec 000-008 * Switzerland 008-03 Ireland 000 008 ** France 000-006 ** : 3 93 : 9 655 :0 000 : 3 0 : 940 : 7 477 :8 000 : 450 * Robillard, P. et al; Transfusion associated circulatory overload: The new leading cause of transfusion associated fatalities reported to the Québec Haemovigilance system. Presentation IHS 00 in Dubrovnik ** ANSM; Mise au point sur les oedèmes aigus pulmonaires de sucharge posttransfusionnels. Juillet 0 5

Definition(s) of TACO ISBT WP on Haemovigilance, July 0: Occurrence of any 4 of the following: Acute respiratory distress Tachycardia Increased blood pressure Acute or worsening pulmonary oedema on frontal chest X-ray Evidence of positive fluid balance within 6 hours of transfusion. An elevated BNP is supportive of TACO Transfusion reactions (Popovsky et al, AABB Press, 3rd edition) Occurrence of any or all of the following: Dyspnoea Orthopnoea Cyanosis Tachycardia Increased blood pressure Pulmonary / pedal oedema within several hours of transfusion Nonspecific manifestations Headache Tightness in the chest Dry cough 6

Number of cases Reports of TACO 008-03 High imputability cases by severity 60 50 40 30 0 Grade 4 Grade 3 Grade Grade 0 0 008 009 00 0 0 03 Year 7

Number of cases Reports of TACO 008-03 All reported cases 60 50 40 possible 30 0 Grade 4 Grade 3 Grade Grade 0 0 008 009 00 0 0 03 Year 8

Number of cases Reports of TACO 008-03 60 50 All reported cases Possible TACO: Only mild cases, except severe in 0 40 30 0 possible Grade 4 Grade 3 Grade Grade 0 0 008 009 00 0 0 03 Year 9

TACO reports 0 & 03 49 TACO, imputability possible, probable or certain 35 high Imputability 4 possible Patient demographics Product type Severity Risk factors Signs and symptoms Preventability (transfusion rate?) 0

number of cases by gender TACO reports 0 & 03 Patient demographics of reported cases 4 3 0 0 8 8 6 5 8 F M 4 3 3 0 5 3 40-49 50-59 60-69 70-79 80-89 90+ Age group

Number of cases Severity 0 & 03 Severity by blood component 0 9 8 6 4 0 Grade Grade 8 6 7 Grade 3 Grade 4 4 4 0 RBC only RBC + PC PC only Product type

Number of cases Severity 0 & 03 Severity by blood component 0 8 6 4 0 8 6 Possibles: RBC RBC + PC RBC + FFP PC Grade Grade Grade 3 Grade 4 4 0 RBC only RBC + PC PC only Product type 3

Number of cases Risk factors Severity of TACO by risk factors 0 8 6 4 Grade Grade Grade 3 Grade 4 0 no known risk factors heart disease only > 60y only > 60y + heart disease Risk factor > 60y + heart disease + renal failure 4

Number of cases Risk factors 0 8 > 60y as only risk: ~ 0 % life threatening events Severity of TACO by risk factors 6 4 Grade Grade Grade 3 Grade 4 0 no known risk factors heart disease only > 60y only > 60y + heart disease Risk factor > 60y + heart disease + renal failure 5

Number of cases Risk factors 0 8 > 60y as only risk: ~ 0 % life threatening events Severity of TACO by risk factors Additional risk factors: 30-50 % life threatening/fatal events 6 4 Grade Grade Grade 3 Grade 4 0 no known risk factors heart disease only > 60y only > 60y + heart disease Risk factor > 60y + heart disease + renal failure 6

Signs and symptoms Reported TACO symptoms Signs and symptoms associated with TACO sweating other agitation loss of consciousness abdominal pain nausea/vomiting hypotension pulmonary oedema chest pain tachycardia hypertension hypoxemia dyspnoea chills fever 4 5 5 8 8 8 30 33 0 5 0 5 0 5 30 35 Number of cases 7

Percent of cases Reported TACO symptoms Frequency of symptoms 80% 70% 60% 50% 40% 30% All cases 0% 0% 0% Hypertension Tachycardia Dyspnoea Hypoxia pulmonary oedema observed symptoms chest pain 8

Percent of cases Reported TACO symptoms Frequency of symptoms 0% 00% 80% 60% 40% Grade Grade Grade 3 / 4 0% 0% Hypertension Tachycardia Dyspnoea Hypoxia pulmonary oedema observed symptoms chest pain 9

percent of cases Reported TACO symptoms combinations of symptoms 00 90 80 70 60 50 40 BP & dyspnoea BP or dyspnoea Dyspnoea & hypoxia 30 0 0 0 Grade Grade Grade 3 / 4 Severity 0

Number of cases Grade 3 &4 TACO - Preventability 3 Transfusion rate and risk factors No Risk factor > 60y >60y + heart disease >60y + heart disease + renal failure 0 unknown -.5 ml/min > - >6 ml/min Transfusion rate

Grade 3 & 4 TACO - Preventability Absence of risk factors transfusion rate: -4 ml/minute One known risk factor Several risk factors Recommended precautions: limit transfusion rate: ml/kg bw/h assess fluid balance careful monitoring of patient consider therapeutic options evaluate patient for each transfusion

Key findings Most reported TACO cases occurred in patients > 60y TACO is mainly associated with RBC transfusion 5 % were life threatening or fatal Age > 60 is the most common single risk factor Several risk factors increased severity 3

Main clinical aspects Presentation hypertension and dyspnoea are the most common but non-specific symptoms The combination of dyspnoea and hypoxaemia indicate an increased likelihood for a life-threatening or fatal course of the event measure saturation! Management of TACO Recognise and act on unspecific symptoms In case of dyspnoea check O-saturation Look out for additional symptoms Consider diuretics, nitrates and oxygen 4

Assess risk factors Prevention Base decision to transfuse on benefit/risk assessment Take overall fluid balance into account In presence of one or more risk factors: Prescribe low transfusion rate of max. ml/kg bw/h Monitor patient carefully (BP, HR, respiration, SaO) Assess patient anew for each unit to be transfused 5

Conclusions TACO is the major remaining preventable risk of transfusion in Switzerland It is mainly observed in elderly patients receiving RBC transfusions Pre-transfusion patient risk assessment is essential Less restrictive definition than proposed by ISBT allows recognition of beginning TACO and probably prevention of a life threatening or fatal course of reaction 6

Conclusions Preventive measures focus on individualised prescription (medical staff) Low transfusion rate in patients at risk for TACO close monitoring of patient during transfusion (nursing staff) Diuretics as premedication were found to have no effect on the severity of reaction* * Robillard, P. et al; Transfusion associated circulatory overload: The new leading cause of transfusion associated fatalities reported to the Québec Haemovigilance system. Presentation at IHS 00 in Dubrovnik 7